Therapeutic Targets for Adrenocortical Carcinoma in the Genomics Era

Adrenocortical carcinoma (ACC) is a rare and often fatal cancer, affecting ~1 person per million per year worldwide. Approximately 75% of patients with ACC eventually develop metastases and progress on the few available standard-of-care medical therapies, highlighting an incredible need for an impro...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohan, Dipika R, Lerario, Antonio Marcondes, Hammer, Gary D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2018
Materias:
Mini-Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215083/
https://www.ncbi.nlm.nih.gov/pubmed/30402590
http://dx.doi.org/10.1210/js.2018-00197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215083/
https://www.ncbi.nlm.nih.gov/pubmed/30402590
http://dx.doi.org/10.1210/js.2018-00197

Ejemplares similares